Get the Stockscreener App
97.47
2.84%
-2.845
After Hours:
97.41
-0.055
-0.06%
Biontech Se Adr Stock (BNTX) Forecast
The Biontech Se Adr (BNTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $228.70, representing a +134.65% increase from the current price of $97.47. The highest analyst price target is $239.53, and the lowest is $217.87.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BNTX Price Target
Average 345.29
(+254.27% Upside)
Is Biontech Se Adr (BNTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.54 | Neutral |
| STOCH(9,6) | 16.19 | Buy |
| STOCHRSI(14) | 2.9172 | Buy |
| MACD(12,26) | -4.4169 | Sell |
| ADX(14) | 18.84 | Neutral |
| William %R | -99.75 | Buy |
| CCI(14) | -107.69 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
107.00
Sell
|
105.46
Sell
|
| MA20 |
112.18
Sell
|
109.59
Sell
|
| MA50 |
115.58
Sell
|
113.24
Sell
|
| MA100 |
114.21
Sell
|
112.37
Sell
|
| MA200 |
104.86
Sell
|
108.50
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BNTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on BNTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.54 indicates that BNTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 16.19 indicates that BNTX is oversold. This indicates that BNTX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.9172 indicates that BNTX is oversold. This suggests that BNTX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.84 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -107.69 indicates that BNTX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term BNTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Biontech Se Adr financial reports and earnings history, Biontech Se Adr (BNTX) stock could reach $334.92 by 2030, $400.65 by 2040 and $2,509.84 by 2050. See the projected annual prices until 2050 of the Biontech Se Adr stock below:
- Biontech Se Adr (BNTX) is expected to reach an average price of $352.33 in 2035, with a high prediction of $353.73 and a low estimate of $333.28. This indicates an $261.50% rise from the last recorded price of $97.47.
- Biontech Se Adr (BNTX) stock is projected to chart a bullish course in 2040, with an average price target of $399.10, representing an $309.48% surge from its current level. The forecast ranges from a conservative $366.61 to a sky-high $400.65.
- Our analysts predict Biontech Se Adr (BNTX) to jump 313.03% by 2045, soaring from $393.66 to an average price of $402.56, potentially reaching $2,066.47. While $393.66 is the low estimate, the potential upside is significant.
- Biontech Se Adr (BNTX) stock is expected to climb by 2050, reaching an average of $2,507.23, a $2,472% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2,509.84 and $2,481.56, respectively, highlighting the market's uncertainty.
Biontech Se Adr Stock (BNTX) Year by Year Forecast
Biontech Se Adr Stock (BNTX) Price Forecast for 2025
Biontech Se Adr Stock (BNTX) is expected to reach an average price of $248.54 in 2025, with a high prediction of $323.79 and a low estimate of $173.30. This indicates an +155.01% rise from the last recorded price of $97.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $219.25 | $217.87 | $239.53 | +124.95% |
| May, 2025 | $228.56 | $212.55 | $231.56 | +134.50% |
| June, 2025 | $256.81 | $221.92 | $257.77 | +163.49% |
| July, 2025 | $281.49 | $247.78 | $290.54 | +188.81% |
| August, 2025 | $301.70 | $263.74 | $309.88 | +209.55% |
| September, 2025 | $269.48 | $268.51 | $314.30 | +176.49% |
| October, 2025 | $313.30 | $272.52 | $315.82 | +221.45% |
| November, 2025 | $298.14 | $293.16 | $320.19 | +205.90% |
| December, 2025 | $323.58 | $293.79 | $323.79 | +232.00% |
Biontech Se Adr Stock (BNTX) Price Forecast for 2026
The predicted value for Biontech Se Adr (BNTX) in 2026 is set at an average of $513.02. Estimates vary from a peak of $704.77 to a trough of $321.26, indicating an +426.36% surge from the present price of $97.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $404.20 | $321.26 | $409.77 | +314.72% |
| February, 2026 | $426.13 | $362.48 | $430.73 | +337.22% |
| March, 2026 | $458.37 | $426.29 | $478.02 | +370.29% |
| April, 2026 | $518.07 | $427.05 | $528.45 | +431.55% |
| May, 2026 | $591.01 | $509.85 | $704.77 | +506.38% |
| June, 2026 | $597.73 | $567.70 | $631.88 | +513.28% |
| July, 2026 | $501.99 | $484.78 | $624.94 | +415.04% |
| August, 2026 | $479.16 | $470.03 | $565.32 | +391.62% |
| September, 2026 | $614.35 | $487.64 | $643.31 | +530.32% |
| October, 2026 | $534.30 | $508.23 | $593.70 | +448.20% |
| November, 2026 | $444.93 | $417.84 | $534.19 | +356.50% |
| December, 2026 | $441.10 | $429.04 | $469.95 | +352.57% |
Biontech Se Adr Stock (BNTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Biontech Se Adr (BNTX) is $486.01, with a high forecast of $555.57 and a low forecast of $416.46. This indicates an +398.66% increase from the last price of $97.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $471.15 | $416.46 | $476.53 | +383.41% |
| February, 2027 | $473.16 | $457.75 | $489.14 | +385.47% |
| March, 2027 | $469.51 | $442.74 | $486.15 | +381.72% |
| April, 2027 | $474.58 | $462.37 | $483.80 | +386.93% |
| May, 2027 | $472.20 | $438.62 | $482.17 | +384.48% |
| June, 2027 | $496.01 | $475.72 | $499.18 | +408.91% |
| July, 2027 | $479.68 | $479.39 | $517.51 | +392.15% |
| August, 2027 | $489.05 | $477.66 | $495.48 | +401.77% |
| September, 2027 | $482.69 | $469.36 | $491.59 | +395.25% |
| October, 2027 | $511.78 | $480.93 | $520.61 | +425.09% |
| November, 2027 | $533.22 | $510.85 | $533.86 | +447.09% |
| December, 2027 | $521.34 | $514.85 | $555.57 | +434.90% |
Biontech Se Adr Stock (BNTX) Price Forecast for 2028
In 2028, Biontech Se Adr (BNTX) is projected to reach an average price of $529.36, with a high projection of $556.33 and a low estimate of $502.39. This indicates an +443.13% rise from the last price of $97.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $520.87 | $513.40 | $527.04 | +434.42% |
| February, 2028 | $516.98 | $512.69 | $529.78 | +430.43% |
| March, 2028 | $519.64 | $512.22 | $528.35 | +433.15% |
| April, 2028 | $515.93 | $512.97 | $527.62 | +429.35% |
| May, 2028 | $510.69 | $502.39 | $524.42 | +423.97% |
| June, 2028 | $524.18 | $510.02 | $528.00 | +437.81% |
| July, 2028 | $526.08 | $518.73 | $528.66 | +439.77% |
| August, 2028 | $532.53 | $521.11 | $535.44 | +446.38% |
| September, 2028 | $553.57 | $531.67 | $556.10 | +467.97% |
| October, 2028 | $546.68 | $538.87 | $556.33 | +460.89% |
| November, 2028 | $539.34 | $532.25 | $553.66 | +453.37% |
| December, 2028 | $550.85 | $536.02 | $553.41 | +465.17% |
Biontech Se Adr Stock (BNTX) Price Forecast for 2029
The 2029 price forecast for Biontech Se Adr Stock (BNTX) is $374.94 on average, with a high prediction of $584.61 and a low estimate of $165.27. This represents an +284.69% increase from the previous price of $97.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $565.11 | $549.42 | $566.87 | +479.81% |
| February, 2029 | $564.21 | $561.89 | $577.58 | +478.89% |
| March, 2029 | $565.35 | $560.23 | $568.68 | +480.05% |
| April, 2029 | $569.36 | $564.10 | $571.96 | +484.17% |
| May, 2029 | $576.71 | $567.87 | $579.43 | +491.71% |
| June, 2029 | $581.22 | $573.34 | $582.02 | +496.34% |
| July, 2029 | $176.04 | $165.27 | $584.61 | +80.62% |
| August, 2029 | $195.34 | $177.97 | $196.01 | +100.42% |
| September, 2029 | $221.40 | $197.49 | $225.18 | +127.16% |
| October, 2029 | $235.14 | $221.13 | $247.71 | +141.26% |
| November, 2029 | $245.14 | $236.68 | $246.54 | +151.52% |
| December, 2029 | $257.75 | $247.76 | $264.71 | +164.45% |
Biontech Se Adr Stock (BNTX) Price Forecast for 2030
Biontech Se Adr Stock (BNTX) is expected to reach an average price of $386.89 in 2030, with a high forecast of $505.85 and a low forecast of $267.92. This signifies an +296.95% surge from the last price of $97.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $287.76 | $267.92 | $334.92 | +195.24% |
| February, 2030 | $299.88 | $282.45 | $306.56 | +207.68% |
| March, 2030 | $316.73 | $302.24 | $324.52 | +224.97% |
| April, 2030 | $341.76 | $318.81 | $343.00 | +250.64% |
| May, 2030 | $379.33 | $344.95 | $400.15 | +289.19% |
| June, 2030 | $380.60 | $370.60 | $388.66 | +290.50% |
| July, 2030 | $390.12 | $371.00 | $393.12 | +300.26% |
| August, 2030 | $424.58 | $385.03 | $425.54 | +335.63% |
| September, 2030 | $439.97 | $420.21 | $440.81 | +351.41% |
| October, 2030 | $483.45 | $440.83 | $491.63 | +396.03% |
| November, 2030 | $457.45 | $456.48 | $497.61 | +369.35% |
| December, 2030 | $505.29 | $462.03 | $505.85 | +418.44% |
1.89%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):